SMSbiotech is excited to have participated in the 5th Annual Age-Related Disease Therapeutics Summit in San Francisco.
During the summit, Dr. Rahmo engaged in discussions on the advantages and disadvantages of using in-vitro reductionist models for age-related diseases and evaluating their potential to model complex mechanisms of aging accurately. Experts in the field are currently exploring how targeted therapies can address the root causes of age-related diseases and conditions by addressing aging.
This event provides a unique opportunity for networking and collaboration with experts, researchers, and industry leaders. We look forward to connecting with colleagues and exploring the latest developments in this rapidly evolving field. Our participation in this summit will not only help us serve different indications but also foster collaborations and progress in the fight against age-related diseases.
.avif)
Please feel free to reach out to us for more information.
